Poverty nearly doubles risk of dangerous diabetes complication in children
Swedish researchers found that children from low-income households are 41% more likely to develop diabetic ketoacidosis when diagnosed with type 1 diabetes. The finding, based on national health records, suggests healthcare systems may need targeted screening and intervention strategies for disadvantaged populations to prevent life-threatening complications at disease onset.
Originaltitel: Relative poverty is associated with increased risk of diabetic ketoacidosis at onset of type 1 diabetes in children. A Swedish national population-based study in 2014-2019
<p>Aims: The aim of the study was to estimate the effect of household relative poverty on the risk of diabetic ketoacidosis at diagnosis of children with type 1 diabetes using an international standard measurement of relative poverty.Methods: A national population-based retrospective study was conducted. The Swedish National Diabetes Register (NDR) was linked with data from Sweden's public statistical agency (Statistics Sweden). Children who were diagnosed with new-onset type 1 diabetes in the period of 2014-2019 were common identifiers. The definition of diabetic ketoacidosis was venous pH &lt;7.30 or a serum bicarbonate level &lt;18 mmol/L. The exposure variable was defined according to the standard definition of the persistent at-risk-of-poverty rate used by the statistical office of the European Union (Eurostat) and several other European public statistical agencies. Univariate and multi-variable analyses were used to calculate the effect of relative poverty on the risk of diabetic ketoacidosis.Results: Children from households with relative poverty had a 41% higher risk of diabetic ketoacidosis (1.41, CI 1.12-1.77, p = 0.004) and more than double the risk of severe diabetic ketoacidosis (pH &lt;7.10) (RR 2.10, CI 1.35-3.25, p = 0.001), as compared to children from households without relative poverty.Conclusions: Relative poverty significantly increases the risk of diabetic ketoacidosis at onset of type 1 diabetes in children, even in a high-income country with publicly reimbursed health care.</p>